These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 9247277)
1. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Kankkunen JP; Harvima IT; Naukkarinen A Int J Cancer; 1997 Jul; 72(3):385-8. PubMed ID: 9247277 [TBL] [Abstract][Full Text] [Related]
2. Mast cells in developing subepidermal bullous diseases: emphasis on tryptase, chymase and protease inhibitors. Kaminska R; Naukkarinen A; Glinski W; Horsmanheimo M; Harvima IT Acta Derm Venereol; 1999 Sep; 79(5):351-5. PubMed ID: 10494709 [TBL] [Abstract][Full Text] [Related]
3. Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin. Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M Arch Dermatol Res; 1990; 282(7):428-33. PubMed ID: 1706585 [TBL] [Abstract][Full Text] [Related]
4. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection. Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866 [TBL] [Abstract][Full Text] [Related]
5. Mast cell tryptase and chymase in developing and mature psoriatic lesions. Harvima IT; Naukkarinen A; Paukkonen K; Harvima RJ; Aalto ML; Schwartz LB; Horsmanheimo M Arch Dermatol Res; 1993; 285(4):184-92. PubMed ID: 8342961 [TBL] [Abstract][Full Text] [Related]
6. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors. Huttunen M; Harvima IT Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975 [TBL] [Abstract][Full Text] [Related]
8. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma. Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999 [TBL] [Abstract][Full Text] [Related]
9. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions. Harvima IT; Haapanen L; Ackermann L; Naukkarinen A; Harvima RJ; Horsmanheimo M Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625 [TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of mast cells in benign and malignant breast lesions. Immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Kashiwase Y; Morioka J; Inamura H; Yoshizawa Y; Usui R; Kurosawa M Int Arch Allergy Immunol; 2004 Jul; 134(3):199-205. PubMed ID: 15178888 [TBL] [Abstract][Full Text] [Related]
11. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin. Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M Int J Dermatol; 1994 May; 33(5):361-6. PubMed ID: 8039976 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-4-positive mast cells are highly associated with the extent of immediate allergic wheal reaction in the skin. Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT Allergy; 2001 Jan; 56(1):58-64. PubMed ID: 11167353 [TBL] [Abstract][Full Text] [Related]
13. Application of novel tissue microarrays to investigate expression of tryptase, chymase and KIT protein in placental mast cells. Noack F; Krüger S; Thorns C; Finas D; Stöcker W; Diedrich K; Horny HP Arch Gynecol Obstet; 2005 Sep; 272(3):223-8. PubMed ID: 16142475 [TBL] [Abstract][Full Text] [Related]
14. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma. Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168 [TBL] [Abstract][Full Text] [Related]
15. An antibody raised against in vitro-derived human mast cells identifies mature mast cells and a population of cells that are Fc epsilon RI(+), tryptase(-), and chymase(-) in a variety of human tissues. Qi JC; Li L; Li Y; Moore K; Madigan MC; Katsoulotos G; Krilis SA J Histochem Cytochem; 2003 May; 51(5):643-53. PubMed ID: 12704212 [TBL] [Abstract][Full Text] [Related]
16. Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic wounds. Huttunen M; Aalto ML; Harvima RJ; Horsmanheimo M; Harvima IT Exp Dermatol; 2000 Aug; 9(4):258-65. PubMed ID: 10949547 [TBL] [Abstract][Full Text] [Related]
17. Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix. Cabanillas-Saez A; Schalper JA; Nicovani SM; Rudolph MI Int J Gynecol Cancer; 2002; 12(1):92-8. PubMed ID: 11860542 [TBL] [Abstract][Full Text] [Related]
18. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand. Li L; Meng XW; Krilis SA J Immunol; 1996 Jun; 156(12):4839-44. PubMed ID: 8648132 [TBL] [Abstract][Full Text] [Related]
19. Quantitation of tryptase- and chymase-containing mast cells in cutaneous lichen planus. Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M Acta Derm Venereol; 1991; 71(5):394-8. PubMed ID: 1721758 [TBL] [Abstract][Full Text] [Related]
20. Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Tetlow LC; Woolley DE Ann Rheum Dis; 1995 Jul; 54(7):549-55. PubMed ID: 7668897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]